BiomX stockholders approve issuance of up to 24.6M shares for purchase agreement

BiomX Inc.

Approval of up to 24,632,245 shares of common stock and shares underlying pre-funded warrants per Securities Purchase Agreement dated Feb 22, 2023.
Vote: 13,535,908 for, 691,362 against, 29,429 abstain; no broker non-votes.
Issuance required to comply with NYSE American listing rules.
Shares authorized for potential equity financing to support operations.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 1.0

BiomX Inc. shareholders approved Approval of the issuance of up to 24,632,245 shares of Common Stock, composed of Shares and Shares underlying pre-funded warrants, in accordance with the Securities Purchase Agreement dated February 22, 2023 at the 2023-04-24 meeting.

Outcome: passed
Meeting: 2023-04-24

Exact text from the filing

The Company’s stockholders voted to approve the issuance of up to 24,632,245 shares of Common Stock, par value $0.0001 each (“Shares”), composed of Shares and Shares underlying pre-funded warrants, in accordance with the Securities Purchase Agreement dated February 22, 2023, in order to comply with the listing rules of the NYSE American. Voted For Voted Against Abstain Broker Non-Votes 13,535,908 691,362 29,429 0

View on SEC.gov

224 shareholder votes filed in the last 30 days. Browse all shareholder votes →

BiomX Inc. filing history →

Source: SEC EDGAR

accession 0001213900-23-032477

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.